secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001213900-26-004348
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 5.02, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX closes private placement, issues 3,300 Series Y Preferred shares; appoints director
--------------------------------------------------------------------------------

- Closed private placement of 3,300 Series Y Convertible Preferred shares and warrants on January 13, 2026.
- Board appointed Reuven Yeganeh as Class 1 director, effective at closing; board size increased to nine.
- Yeganeh is CEO of Continual Ltd. and independent under NYSE American rules; since 2024 also director of Nukkleus Inc.
- Company entered into standard indemnification agreement with Yeganeh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/0001213900-26-004348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026004348/ea027293801-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-004348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer